IL17A and arthritic joint disease: On the other hand, following the administration of this recombinant strain in a model of arthritis, the oral treatment decreased levels of IL-17 and IFN-γ and prevented inflammatory infiltration and bone degeneration in the tissue (Gusmao-Silva et al., 2020).